For example, treatment with STAT3 inhibitors can suppress the frequency of liver-associated MDSCs to inhibit tumor growth and dampen the suppressive function of MDSCs to enhance the anticancer efficacy of chimeric antigen receptor T (CAR-T) cells [85]. The gene discussed is STAT3; the disease is neoplasm.